Oral antiplatelet efficacy and specificity of a novel nonpeptide platelet GPIIb/IIIa receptor antagonist, DMP 802.
Mousa SA, Olson RE, Bozarth JM, Lorelli W, Forsythe MS, Racanelli A, Gibbs S, Schlingman K, Bozarth T, Kapil R, Wityak J, Sielecki TM, Wexler RR, Thoolen MJ, Slee A, Reilly TM, Anderson PS, Friedman PA.
Mousa SA, et al. Among authors: wexler rr.
J Cardiovasc Pharmacol. 1998 Aug;32(2):169-76. doi: 10.1097/00005344-199808000-00001.
J Cardiovasc Pharmacol. 1998.
PMID: 9700976